BCTXZ

BriaCell Therapeutics Corp. Warrant BCTXZ

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BCTXZ PTIX MLEC ARTL DRMA VRAX ESLA GLMD AIMD XRTX
6M -68.33 % 9.90 % -90.55 % -31.54 % 461.37 % -33.35 % 110.46 % -2.14 % 47.04 % 26.44 %
YTD -68.33 % -55.71 % -92.08 % -35.93 % 185.61 % -72.46 % 56.25 % -58.73 % 58.80 % -5.98 %
1Y -68.33 % -67.14 % -92.52 % -43.68 % 154.49 % -62.66 % 110.34 % -70.73 % 39.30 % -35.67 %
3Y -68.33 % -90.76 % -93.56 % -76.41 % -97.46 % -96.07 % -82.67 % -98.17 % -88.24 % -86.78 %
5Y -68.33 % -97.46 % -93.37 % -92.28 % -99.68 % -99.67 % -82.05 % -99.77 % -93.08 % -96.11 %
10Y -68.33 % -97.46 % -93.37 % -99.00 % -99.68 % -99.67 % -82.05 % -99.92 % -93.08 % -96.11 %
From the beginning -68.33 % -97.46 % -93.37 % -99.00 % -99.68 % -99.67 % -82.05 % -99.95 % -93.08 % -96.11 %

Dividend

Protagenic Therapeutics, Inc.

XORTX Therapeutics Inc.